Our work

Wysa: AI-guided mental health support

AI has the potential to address some of the healthcare industry’s greatest problems today, but it first must overcome consumer wariness and an evolving regulatory environment. Wysa pioneered clinically-validated AI-guided mental health support, touting FDA Breakthrough Device Designation and partners including the NHS and the Singapore Ministry of Health. With a flourishing consumer user base, Wysa tapped Diffusion to help distinguish its platform from competitors in the crowded mental health market and further expand its B2B arm.

Insight & Idea

Diffusion faced an uphill battle when it came to media comprehension and trust in a new application of AI for mental health. Leveraging third party research, institutional validation and real customer stories, Diffusion equipped reporters with objective data backing the efficacy of Wysa, alongside the opportunity to try out the platform for themselves. Actioning on key moments in the business news cycle, from rolling layoffs to quiet quitting, Diffusion was able to generate significant and consistent coverage positioning Wysa as the next generation must-have company benefit for employee job satisfaction, productivity and increased tenure.

Impact & Action

The campaign generated over 380 pieces of coverage in top-tier outlets including NPR, CNBC, Fortune, and The Wall Street Journal. Diffusion’s work educating reporters turned skeptics into believers, resulting in positive features including a pivotal NPR article that later influenced partner decisions. The effort led to 3.9 billion impressions, a 300% YTD growth in organic traffic, and over 250 inbound leads within 1 year of the campaign. Wysa became a go-to media source on mental health AI and was featured in Bill Gates’ blog and Business Insider’s list of top AI healthcare leaders.